RBC Capital Cut Price Target on United Natural Foods (UNFI) Following 3Q Results

BMO Capital Cuts Price Target Following United Natural Foods (UNFI) 3Q Results

BMO Capital maintains an Outperform rating on United Natural Foods (NASDAQ: UNFI), and cut the price target to $71.00 (from $75.00), following UNFI's 3Q results. UNFI reported EPS of $0.83, below consensus estimate of $0.85. Analyst Kelly Bania believes that there were still several positive developments that seem to have been overlooked.

Bania commented, "While signs of industry weakness heading into UNFIs F3Q15 results were not lacking, we believe there were several positivedevelopments that seem to be overlooked, including 1) transitory issues... More

Canaccord Genuity Cuts Price Target on United Natural Foods (UNFI) Following Q3 Results

Canaccord Genuity reiterates a Buy rating on United Natural Foods (NASDAQ: UNFI), and cut the price target to $71.00 (from $85.00), following Q3 results. UNFI reported EPS of $0.83 that came in $0.02 below the consensus forecast of $0.85. Revenue of $2.11 billion fell short of Streets $2.14 billion.

Analyst Scott Winkle,... More

Piper Jaffray Cuts Price Target to United Natural Foods (UNFI) Following Q3

Piper Jaffray reiterates an Overweight rating on United Natural Foods (NASDAQ: UNFI), and cut the price target to $80.00 (from $81.00), following the company's Q3 earnings report. UNFI reported sales of 2.12B came in below consensus expectations of 2.14B. EPS was reported at $0.83 vs. consensus estimate of... More

Jefferies Cuts Price Target Following United Natural Foods (UNFI) Q3 Results

Jefferies reiterates a Buy rating on United Natural Foods (NASDAQ: UNFI), and cut the price target to $84.00 (from $90.00), following its 3Q results. UNFI reported EPS of $0.83 vs. consensus $0.85.

Analyst Mark Wiltamuth commented, "While 3Q certainly had its issues (weak sales and gross... More

After-Hours Stock Movers 06/08: (NAVB) (PBY) (PLAY) Higher; (UNFI) (STV) (NBIX) Lower (more...)

Navidea Biopharmaceuticals (NYSE: NAVB) 12.7% HIGHER; announced that results from an investigator-initiated, comparative study of Lymphoseek® (technetium Tc 99m tilmanocept) injection versus filtered Tc-99m Sulfur Colloid (fTcSC) measuring injection site pain in patients with breast cancer undergoing lymphoscintigraphy were presented at the 2015 Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference. The results of the randomized, double-blinded trial, led by Anne Wallace, M.D., professor of surgery at University of California, San Diego School of Medicine, highlighted that fTcSC caused statistically significant greater levels of pain after injection compared... More

United Natural Foods (UNFI) Misses Q3 EPS by 2c; Trims FY15 Outlook

United Natural Foods (NASDAQ: UNFI) reported Q3 EPS of $0.83, $0.02 worse than the analyst estimate of $0.85. Revenue for the quarter came in at $2.11 billion versus the consensus estimate of $2.15 billion.

United Natural Foods sees FY2015 EPS of $2.84-$2.88, versus the consensus of $2.92. United Natural... More

Trading Radar for 6/8: Sears (SHLD), FuelCell (FCEL), H&R Block (HRB), Vail Resorts (MTN), Dave & Buster's (PLAY) Report

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Earnings:

Bio-reference Labs, Inc. (Nasdaq: BRLI) - consensus EPS $0.44
Jiayuan.com (Nasdaq: DATE) - consensus Loss... More